#Triplatin, eine 30 Jahre alte Substanz, könnte einer aktuellen Studie in „Molecular Cancer Therapeutics“ zufolge wirksam bei #triplenegativebreastcancer, triple-negativem #Brustkrebs, sein. https://t.co/vKbgmkRNgy https://t.co/7MxpBiF1qc
Research by a team at @VCUMassey shows that a 30-year-old drug is effective against triple negative breast cancer, which is the most aggressive form of breast cancer. https://t.co/37z978JnFl The study was published on the @NCBI website: https://t.co/wWTKa
Exploitation of Sulfated Glycosaminoglycan Status for Precision Medicine of Triplatin in Triple-Negative Breast Cancer. https://t.co/LzvhnpJYZq https://t.co/P4zA8cja0O
Congratulations @KoblinskiLab ! Keep up the excellent work !
RT @JaniceTNBCmets: Old drugs as future tx options? 👏🏻 In-vivo/ 🐭 study of Triplatin for #TNBC “Triplatin decreased primary tumor growth, r…
Old drugs as future tx options? 👏🏻 In-vivo/ 🐭 study of Triplatin for #TNBC “Triplatin decreased primary tumor growth, reduced lung metastases, & inhibited metastatic growth in lungs, liver, & ovaries.” #metastaticbreastcancer #research #bcsm https:
RT @KoblinskiLab: Mine & Dr Farrell’s group with co-first author David Hampton & Erica Peterson have published a promising study that exp…
RT @KoblinskiLab: Mine & Dr Farrell’s group with co-first author David Hampton & Erica Peterson have published a promising study that exp…
Mine & Dr Farrell’s group with co-first author David Hampton & Erica Peterson have published a promising study that explores sGAG levels as a predictor of TNBC response to platinum therapy developed by Dr Farrell @VCUChemistry Thanks @VCUMassey @
RT @VCUChemistry: Professor Farrell and coworkers have published a promising study that explores sulfate glycosaminoglycan levels as a pred…
RT @VCUChemistry: Professor Farrell and coworkers have published a promising study that explores sulfate glycosaminoglycan levels as a pred…
Professor Farrell and coworkers have published a promising study that explores sulfate glycosaminoglycan levels as a predictor of triple-negative breast cancer response to platinum therapy in Molecular Cancer Therapeutics. https://t.co/w48JnR0zJO @VCUresea
👩🔬👨🔬 Led by Dr. Jennifer Koblinski (@KoblinskiLab), researchers at Virginia Commonwealth University ( @VCUChemistry) explored sulfated #glycosaminoglycan levels as a predictor of #TNBC response to platinum therapy. Sound interesting? Read more 👇 https:/
🙌🙌🙌
New article: Exploitation of sulfated glycosaminoglycan status for precision medicine of Triplatin in triple-negative breast cancer https://t.co/ivAbiPP8XV #lungcancer #oncology https://t.co/9luKCsfujO
New article: Exploitation of sulfated glycosaminoglycan status for precision medicine of Triplatin in triple-negative breast cancer https://t.co/CvrdnrADIb #livercancer #oncology https://t.co/2OSkOXLJKW
New article: Exploitation of sulfated glycosaminoglycan status for precision medicine of Triplatin in triple-negative breast cancer https://t.co/iXlW1Qymvq #breastcancer #oncology https://t.co/mknCFMqe63
RT @TSFarmTurner: Number 14!... I think Exploitation of sulfated glycosaminoglycan status for precision medicine of Triplatin in triple-ne…
Number 14!... I think Exploitation of sulfated glycosaminoglycan status for precision medicine of Triplatin in triple-negative breast cancer Published in Molecular Cancer Therapies https://t.co/sMSHEDfDDW #Turner #Farrell @VCUChemistry @VCUCHS #NTTFac